BioNeMo Platform Accelerate AI-Driven Drug Discovery
gmays Sunday, January 18, 2026
Summary
NVIDIA's BioNeMo platform has been adopted by leading life sciences companies to accelerate AI-driven drug discovery, allowing researchers to more efficiently analyze massive datasets and identify promising drug candidates.
1
0
Summary
nvidianews.nvidia.com